JournalofPharmaceuticalandBiomedicalAnalysis165(2019)1–11
ContentslistsavailableatScienceDirect
Journal
of
Pharmaceutical
and
Biomedical
Analysis
jou rn al h om e p a g e :w w w . e l s e v i e r . c o m / l o c a t e / j p b a
Paeonia
arietina
and
Paeonia
kesrounansis
bioactive
constituents:
NMR,
LC-DAD-MS
fingerprinting
and
in
vitro
assays
Stefania
Sut
a,
Gokhan
Zengin
b,∗,
Stefano
Dall’Acqua
c,
Markéta
Gazdová
d,
Karel ˇSmejkal
d,
Gizem
Bulut
e,
Ahmet
Dogan
e,
Mehmet
Zeki
Haznedaroglu
f,
Muhammad
Zakariyyah
Aumeeruddy
g,
Filippo
Maggi
h,
Mohamad
Fawzi
Mahomoodally
gaDAFNAE,DepartmentofAgronomy,Food,Naturalresources,AnimalsandEnvironment,UniversityofPadova,Vialedell’Università,
16,35020Legnaro,PD,Italy
bSelcukUniversity,ScienceFaculty,DepartmentofBiology,Campus,42250,Konya,Turkey
cNPLlab,DepartmentofPharmaceuticalandPharmacologicalSciences,UniversityofPadova,ViaMarzolo,35121,Padova,Italy
dDepartmentofNaturalDrugs,FacultyofPharmacy,UniversityofVeterinaryandPharmaceuticalSciencesBrno,Palackého1/3,61242,Brno,Czech
Republic
eMarmaraUniversity,PharmacyFaculty,DepartmentofPharmaceuticalBotany,Istanbul,Turkey fIzmirKatipCelebiUniversity,PharmacyFaculty,DepartmentofPharmaceuticalBotany,Izmir,Turkey gDepartmentofHealthSciences,FacultyofScience,UniversityofMauritius,230Réduit,Mauritius hSchoolofPharmacy,UniversityofCamerino,Camerino,Italy
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received24September2018 Receivedinrevisedform 14November2018 Accepted16November2018 Availableonline19November2018 Keywords: Paeoniaarietina Paeoniakesrounansis Antioxidant Cholinesterase Tyrosinase ␣-Glucosidase ␣-Amylase
a
b
s
t
r
a
c
t
Paeoniaspecieshavebeen valuedfortheir ethnomedicinalusesinvarious countriesand received
muchinterestamongthescientificcommunityfortheirtherapeuticproperties,includinganti-microbial,
anti-inflammatory,anti-cancer,nephroprotectiveandhepatoprotectiveeffects.Themultiple
phytother-apeuticalapplicationsofPaeoniaspeciesinspiredustoestablishthephytochemical fingerprintand
toevaluatethebiologicalpropertiesofethylacetate,methanol,andaqueousextractsfromtheroots
andaerialpartsoftwoPaeoniaspecies(P.arietinaG.Anderson andP.kesrounansisThiébaut).
Phy-toconstituentsofP.arietinaandP.kesrounansisextractswereanalyzedusing1Dand2DNMRand
LC-DAD-ESI-MS.Thetotalcontentofphenolics(TPC)andflavonoids(TFC)intheextractswasalso
eval-uated.TheantioxidantactivitywasprofiledusingDPPH,ABTS,CUPRAC,FRAP,phosphomolybdenum,
andmetalchelationassays.Enzymeinhibitorypropertieswereevaluatedagainstacetylcholinesterase
(AChE),butyrylcholinesterase(BChE),tyrosinase,␣-amylase,and␣-glucosidase.Phytochemical
analy-sisofP.arietinaandP.kesrounansisextractsshowedthepresenceofgalloylestersofsugars,galloyl
monoterpenes,andglycosylatedflavonoids.Thethreesolventextractspresenteddifferentbehaviorin
thebioassays.Thehighestantioxidantactivity,tyrosinaseandAChEinhibitionwereobservedforthe
methanolicextractoftheaerialpartsofP.kesrounansis.Inaddition,theethylacetateextractsofthe
aerialpartsofbothplantswerethemosteffectiveinhibitorsof␣-amylase.ThehighestBChEinhibition
wasobservedforrootmethanolicextractofP.kesrounansiswhiletherootethylacetateextractofP.
ari-etinaexertedthestrongestinhibitionof␣-glucosidase.MethanolextractofP.kesrounansisaerialparts
presentedthehighestTPC,whileTFCwasgreatestinthecorrespondingextractofP.arietina.Ourfindings
canbeconsideredasastartingpointforfuturestudiestofurthervalidatetheeffectivenessandsafety
profilesoftheseplantsinfolkmedicine.
©2018ElsevierB.V.Allrightsreserved.
∗ Correspondingauthor.
E-mailaddresses:stefaniasut@hotmail.it(S.Sut),gokhanzengin@selcuk.edu.tr(G.Zengin),stefano.dallacqua@unipd.it(S.Dall’Acqua),gazdova.marketa@seznam.cz(M. Gazdová),karel.mejkal@post.cz(K. ˇSmejkal),gizem.bulut@marmara.edu.tr(G.Bulut),adogan@marmara.edu.tr(A.Dogan),zeki.haznedaroglu@ikc.edu.tr(M.Z.Haznedaroglu),
muhammad.aumeeruddy2@umail.uom.ac.mu(M.Z.Aumeeruddy),filippo.maggi@unicam.it(F.Maggi),f.mahomoodally@uom.ac.mu(M.F.Mahomoodally).
https://doi.org/10.1016/j.jpba.2018.11.040
1. Introduction
ThegenusPaeonia(Paeoniaceae)consistsof36acceptedspecies
recordedinThePlantList(http://www.theplantlist.org/).Thegenus
isdividedintothreesections:(1)PaeoniaL.(whichisdistributed
fromSpainandNorth Africaeastwards toChinaandJapan), (2)
MoutonDC. (Eastern Asia)and (3) Onaepia Lindl.(North
Amer-ica).Paeoniaisrepresentedbyninespecieswithninesubspecies
inEurope.InTurkey,thewildPaeoniaspeciesarerepresentedby
eighttaxa[1].Membersofthisgenusareknownfortheirdiverse
colorofflowers,flowertype,andplantheight.Theexuberantcolor
oftheflowersjustifiestheimportanceofPaeoniaspp.asornamental
plantswhiletheknownwound-healingpropertiesofrootssupport
itsuseasherbalmedicine[2].
Paeoniaspp.havealonghistoryofuseastraditional
medici-nalplants.Paeoniaofficinalis and P.mascula werementioned in
“AbouttheAntidotes”belongingtothefirstand largestsection
“ElementAlpha”ofNikolaosMyrepsos’Dynameron, amedieval
medicalmanuscript [3]. TherootofP.officinalis isusedtocure
nervediseasesinJordan[4].InPakistan,P.emodiisadministered
forthetreatmentofrheumatism[5],urinaryproblems,nervous
diseases,colic,headache,asabloodpurifier[6],andtotreat
gen-eralbody weakness [7]. A great number of studieshas proved
thebiological effects ofthe membersof Paeonia genus,
includ-ingthe anti-proliferative activityof P. lactiflora[8], anti-cancer
activityofP.moutan[9],andnephroprotectiveeffectofP.emodi
[10]. With respecttoone of thespecies includedin this work,
thedecoctionoftheaerialpartofP.masculasubsp.arietina(syn.
P.arietina)wasreportedforuseinthemanagementofdiabetes
in the traditional folk medicine in Ovacık (Tunceli) in Turkey
[11], as well as in East Anatolia [12]. In other regions across
Turkey,rootinfusionsareusedassedative,laxative,andfor
treat-mentofepilepticseizureand trecough[13]. Paeoniaspeciesare
knowntobearich sourceof monoterpenespossessinga
‘cage-like’pinane skeleton [14]. Furthermore, othermonoterpenoids,
flavonoids,polyphenols(includingpaeonolandgallicacid
deriva-tives),steroids,andtriterpenoidswerepreviouslydescribedinthis
genus[15].
DespitetheimportanceinTurkishtraditionalmedicine,there
isalackofinformationonthephytoconstituentsofP.arietinaG.
Anderson(previouslyknownasP.masculasubsp.arietina)andP.
kesrounansisThiébaut(previouslyknownasP.turcica).Onlyone
study[16]investigatedthecompositionoftheessentialoilandthe
antioxidantactivity(DPPHand nitricoxidescavenging)ofthese
species,thereforewefocusedonthenon-volatilecompoundsand
theevaluationoftheirbiologicalproperties.Theobjectivesofthe
presentstudyweretoelucidatethephytochemicalcompositionof
P.arietinaandP.kesrounansisbyNMR(1and2D)and
LC-DAD-ESI-MS,andtoassesstheantioxidantandenzymeinhibitoryproperties
ofdifferentextractsfromthosespecies,namelymethanol(MeOH),
ethyl acetate (EA) and water. These extracts were tested for
antioxidantactivityusingDPPH,ABTS,FRAP,CUPRAC,
phospho-molybdenumandmetalchelatingassays.Furtherassaysevaluated
theinhibitorypotentialeffect againstkey enzymesofpotential
clinicalrelevance(cholinesterases,tyrosinase,␣-amylaseand
␣-glucosidase).
2. Materialandmethods
2.1. Plantmaterialandextraction
Theplant sampleswere obtainedfrom a field study in July
of2016:P.arietinaG.Anderson(Tunceli-Pertek,Pınarlarvillage,
1450m),voucherspecimenno.MARE-12500,andP.kesrounansis
J.Thiébaut (Denizli-Acıpayam,Bozda˘g, 1400m), voucher
speci-menno.MARE-17253.Itsbotanicalconfirmationwasdonebya
botanist(Prof.ErtanTuzlaci,MarmaraUniversity,Departmentof
Pharmacology).One plantsample for each Paeonia species was
keptasvoucherspecimenandwasdepositedinMarmara
Univer-sity,FacultyofPharmacy’sHerbarium.Tengramsofplantmaterials
(dried-powderedaerialpartsorroots)weremaceratedin200mlof
ethylacetate(EA)andmethanol(MeOH)atroomtemperaturefor
24h.Theextractswerethenfilteredandconcentratedat40◦C.The
waterextractwaspreparedusinganinfusionasfollows:5gplant
materialwaskeptin100mlboiledwaterfor20min.Theobtained
extractwaslyophilizedandkeptina refrigerator(at4◦C)until
furtheranalysis.
2.2. Totalphenolicandflavonoidcontent
The total phenolic content (TPC) wasdetermined using the
Folin-Ciocalteumethodandflavonoidscontent(TFC)bytheAlCl3
method.Theresultsobtainedwere expressedasequivalents of
standardcompounds(gallicacid(mgGAE/gsample)forTPC)and
rutin(mgRE/gsample)forTFC),respectively)[17].
2.3. Determinationofantioxidantandenzymeinhibitoryeffects
Antioxidantpropertiesofextractswerescreenedbychemical
assaysincludingantiradicalmethods(ABTSandDPPH),reductive
power(CUPRACandFRAP),phosphomolybdenum,andchelating
effect.Theresultswereexpressedasstandardcompounds
equiv-alents (mgTE/g sample and mg EDTAE/gsample). Allmethods
aredescribed in ourpreviouspaper[17]. Theinhibitory effects
of Paeonia extracts wereinvestigated onkey enzymes, namely
cholinesterase (associatedwithneurological disordersincluding
Alzheimer’sdisease),tyrosinase(linked withskindisorders),
␣-amylaseand␣-glucosidase(bothrelatedwithdiabetesmellitus).
Theexperimentalprotocolswerereportedinourpreviouspaper
[17]. Results were expressed as content of standard inhibitors
in samples.Standard inhibitors for cholinesterases were
galan-thamine(mgGALAE/gsample),kojicacidfortyrosinase(mgKAE/g
sample),and acarbose for ␣-amylase and ␣-glucosidase (mmol
ACAE/gsample).
2.4. NMRanalysis
1D-and2D-NMRspectrawereobtainedonaBrukerAvance
III400Ultrashield spectrometerwithsuperconducting 400MHz
magnetsystem.NMRspectrawereacquiredinMeOD-d4
(Sigma-Aldrich)withTMSasaninternalstandard.Durian®4.95mmNMR
tubes(DurianGroup)wereused.Chemicalshiftsareexpressedinı
valuesinppm.1H-NMRandHSQC-DEPT,HMBC,COSYexperiments
wereacquiredusingstandardBrukersequencesmeasuringp1and
d1foreachacquiredsample.
2.5. HPLC-DAD-MSanalysis
Quantitativeanalysisofphenolicderivativeswasobtainedby
LC-DAD-ESI-MSn. The measurements were performed using an
Agilent1260chromatograph(SantaClara,CA,USA)equippedwith
1260diodearraydetector(DAD)andVarianMS-500iontrapmass
spectrometer.Sample separationwasachievedusinganAgilent
EclipseXDBC-18(3.0×150mm,particlesize3.5m)asstationary
phase.Themobilephasewaswater(0.1%formicacid)(A)and
ace-tonitrile(B).Theelutiongradientstarted90:10(A:B)upto0:100
(A:B)at30min,with5minofre-equilibrationtime;flowratewas
0.5ml/minandinjectionvolumewas10L.Attheendofthe
col-umn,aTsplitterseparatedtheflowratetoDADandMS.TheDAD
detectorwasusedtoquantifyflavonoidsandgalloylderivatives.
Rutin(SigmaAldrich,St.Louis,MO, USA)andgallicacid(Sigma
S.Sutetal./JournalofPharmaceuticalandBiomedicalAnalysis165(2019)1–11 3
Fig.1.1H-NMRspectraofthetestedmethanolextracts(1-P.kesrounansisaerialpart;2-P.arietinaaerialpart;3-P.kesrounansisroot;4-P.arietinaroot).
andflavonolderivativesweremonitoredat280nmand 350nm
andUV–vis spectrawereacquiredin therangeof 200–650nm.
MSspectrawererecordedintherangeofm/z50–2000,usingESI
ionsourceoperatinginnegativeionmode.Turbodatadependent
scanning(TDDS)instrumentfunctionwasusedtoacquiredmass
fragmentationpathwaysofthemainionicspecies.Identificationof
compoundswasobtainedbasedonfragmentationspectraaswell
asthecomparisonwiththeliteratureandreferencecompounds,
whenavailable.Themethodofcalibrationcurvewasusedforthe
quantificationofphenolicconstituents:rutinwasusedasexternal
standard for flavonoid quantification, gallic acid was used for
galloylderivatives.Calibrationcurveswereasfollowsy=52.95x
+2.88(R2=0.996)forrutin;y=38.387x+202.53(R2=0.996)for
gallicacid.
2.6. Statisticalanalysis
All tests were carried out in triplicates and findings are
expressed as mean value±SD. SPSS v. 17.0 was employed for
statisticalanalysis.One-wayANOVAwasdonetodetermineany
differencesbetweenthetestedsamplesfollowedbyTukey’stest.
p<0.05wereassignedtobestatisticallysignificant.Theprincipal
component(PCA),clusterandPearsonlinearcorrelationwasused
toevaluatetheassociationbetweentotalbioactivecomponentsand
thefindingsofbiologicalactivity.
3. Resultsanddiscussion
3.1. PhytochemicalfingerprintingofPaeoniaextracts
Phytochemicalcompositionofaerialpartsandrootswas
stud-iedbyNMRandLC-DAD-ESI-MSapproaches.Themethanolextract
wasusedbecauseoftheabilityofthissolventtosolubilizeboth
lipophilic and hydrophilic constituents. 1H-NMR as well as 2D
experiments, namely HSQC-DEPT, HMBC, and COSY were
con-ductedtoidentifytheprincipalconstituentsofthePaeoniaextracts.
1H-NMRoftherootandaerialpartsofP.kesrounansisandP.
ari-etinarevealedthatpartsofthespectraarealmostsuperimposable,
asvisibleforexampleintheregionbetweenı8.5-5.80ppm,
sug-gestingsimilarqualitativecompositionofphenolicconstituents,
andintheregionı3.0–4.2ppmsupportingtheideaofsimilarityin
sugarmoieties.Differenceswereobservedinthespectralregionı
5.6-4.2ppm,whichshowedsignalsascribabletoanomericprotons,
sp2olefinicsignals,ordeshieldedCH
2Ogroups.Furtherdifferences
wereobservedin theregionı2.8-0.5ppm,indicating the
pres-enceofdiversealiphaticcompoundsororganicacidsinthesetwo
extracts.Consideringthegeneralaspectsofanalysisofthesetwo
extracts,largesimilaritywasobservedinspectra,supportinga
sim-ilarcomposition.Exemplificativeprotonspectraofthefourextracts
arereportedinFig.1.
NMRtechniquesallowedustheobservationofdifferenttypes
ofconstituentsintheextracts,anddataobtainedbytheacquisition
of1H-NMR,HSQC-DEPT,andHMBCrevealedthepresenceofsome
ofthetypicalphytoconstituentspresent inPaeoniaspecies[18].
1H-NMR,HSQC-DEPTandHMBCspectraarereportedinFigs.2–5.
Someofthemostintensivesignalsarerelatedtothepresenceof
sugarmoietiesduetotypicalprotonshiftsat␦3.0–4.5ppm.
Fur-thermore,peakssupportingthepresenceofphenolicconstituents
werealsodetected,asdescribedabove.Signalsascribableto
aro-matic acid derivatives couldbe observed in the regionfrom ␦
7.47to8.00ppmasdoubletsordoubletsofdoublets.Moreover,
estersofgallicacidwithsugarsweredetectedduetothepresence
ofsingletsat␦6.89–7.12ppm(relatedtothepositions2 ´and6 ´of
galloylmoiety)[19] andduetothepresenceofsignalsassigned
tosugarpartsasthedoubletat␦6.23, relatedtotheanomeric
protonof glucose/hexose,or thedoubletsand doubletsof
dou-bletsobservedat␦5.5and6.0ppm.HSQC-DEPTdataconfirmed
theassignmentsallowingtheassignmentofnon-quaternary
posi-tionofconstituents,andlaterdiagnosticHMBCcorrelationswere
observedfromtheH-2orH-3signalsofhexoseunitswith
car-bonsat␦164.0–165.5, confirmingthepresenceof esterlinkage
(Table1).Thepresenceofmonoterpenicglycosidicderivatives,like
paeoniflorine[20],couldbesupportedbythediagnosticsignals␦
1.3to5.4ppm,ascribabletothemonoterpenicunit,e.g.signalof
themethylgroupat␦1.39ppm(H-10),signalsoftheCH2groups
forH-2andH-5,asingletat␦5.43ppm(H-9),andsignalsofthree
quaternarycarbonsat␦86.2,87.5and75.4ppmrelatedtoC-1,
C-6andC-7,respectively(Fig.4).ThiswasconfirmedbyHSQC-DEPT
andHMBCanddiagnosticsignalsaresummarizedinTable1.Signals
supportingthepresenceofglycoside,namelythecrowdedregion␦
3–4.5ppmaswellasdoubletsorsingletsassignedtoanomeric
pro-tonpositionsweredetected.Significantamountofsaccharosewas
detectedduetothepresenceofitsanomericsignalat␦5.38ppm.
Fig.2.Exemplificative1H-NMRofthemethanolextractofPaeoniawiththemainassignedpeaks.
Fig.3. ExemplificativeHSQCspectrumofthemethanolicPaeoniaextractwithsomeoftheidentifiedpositionofcompounds.
HMBC,asthemethylgroupcorrelatedwiththecarbonsignalatC-5
oftheglycoside.
Otherconstituentspresentinloweramountswereflavonoids,
inparticularkaempferolandquercetinglycosides.Twodoublets
at␦8.01and6.87ppm(J=7.0Hz)wereascribedtopositions
H-2´,6 ´and3´,5 ´ofkaempferolandthesignals␦7.05,6.96,6.89ppm
wereassigned to positions 2´, 3 ´and6 ´of thering Bof quercetin
[20]. Signalsrelated topositions6 and8offlavonoids couldbe
detectedassinglets␦ 6.4–6.7ppm suggestingtheposition7 as
implicatedinglycosidicbond.HSQC-DEPT,HMBCandCOSYdata
allowedustoconfirmtheassignmentsofthesediagnosticpositions
[20].
The most significant NMR assignments of the compounds
presentinthePaeoniaextractsaresummarizedinFigs.2–4[18,19].
NMRanalysisrevealedthepresenceofaromaticacidderivatives,
gallic acidesters,monoterpene glycosides, as wellas flavonoid
glycosides.Averysimilarfingerprintwasobservedforthe
differ-entmethanolicextractsofrootsandaerialpartsofbothanalyzed
species.
Tofurtherstudythecompositionoftheextracts,
LC-DAD-ESI-MS analysis was performed. Detected peaks were assigned to
compoundsonthebasis ofthecomparisonofUVspectrumand
MSfragmentationpatterns,aswellasbycomparingtheobtained
datawiththoseacquiredintheNMRexperiments.Froma
qual-itativepointofview,theLC-DAD-ESI-MSanalysisconfirmedthe
constituentsidentifiedbyNMR.Quercetinandkaempferol
glyco-sidesandgalloylglucosederivativeswereidentifiedonthebasis
S.Sutetal./JournalofPharmaceuticalandBiomedicalAnalysis165(2019)1–11 5
Fig.4. EnlargedareaoftheHSQC-DEPTspectrumofPaeoniaextractshowingtheassignmentsofthemonoterpenoidderivativeofpaeoniflorinetype.
Fig.5. ExemplificativeHMBCspectrum.
withthatreportedinliterature[21].Quantitativeanalysiswas
per-formedusingrutinasreferencecompoundforflavonoids,andgallic
acidforthe gallicacidderivatives ofsaccharides and
monoter-penes,respectively.Themaincomponentsidentifiedaredepicted
inFig.6.AnalysisofP.arietinaaerialpartsextractshowedthat
themostabundantflavonoidinallofthesampleswas
quercetin-glucosyl-rhamnoside.Thehexagalloylglucoseappearedtobethe
mostabundantgalloylderivativeinalloftheextracts.Fivedifferent
peaksascribabletogalloylpaeonidinweredetectedsuggestingthe
possibilityoffivedifferentesterificationsofgallicacidonhexose
moietyaswellasonpaeonidinfreehydroxylgroup.Theoverviewof
dataagainshowedaverysimilarqualitativecompositionofthefour
samplesanalyzed.Fromaquantitativepointofview,P.
kesrounan-sisandP.arietinaaerialpartswerebothricherinflavonoidsandin
galloylderivativescomparedtotheroots(Table2and3,
respec-tively).
3.2. Totalamountofphenolicsandflavonoids
Thedifferent extractsofP.arietinaand P.kesrounansis were
investigated for their total phenolic content (TPC) and total
flavonoidcontent(TFC)andresultsarepresentedinFig.7.
TheaerialpartextractsofP.arietinahadhigherTPCandTFC
valuescomparedtotherootextracts.Themethanolextractofthe
aerialpartsshowedthehighestTPC(164.10mgGAE/gextract)and
TFC(34.18mgRE/gextract)amongthethreesolvent.Similarly,for
rootpartswefoundthatTPCwasgreatestinthemethanolicone
(85.31mgGAE/gextract)whereastheaqueousrootextract
con-tainedthehighestamountofflavonoids(2.10mgRE/gextract).The
lowestTPCandTFCwereobservedintheaqueousandethylacetate
extractoftheroot,respectively.Asimilarobservationwasnotedfor
P.kesrounansiswherebytheaerialpartsshowedgreaterTPCand
Table1
1Hand13CNMRdiagnosticpositionsforthephytoconstituentsinthemethanolextractsofP.arietinaandP.kesrounansis.
Compounds ␦H(JinHz) ␦CHSQC-DEPT ␦CHMBC
p-OH-benzoicacidmoiety 8.05d,7.48d,(J=7.7,7.6)(H-2´,6´) 128.8,127.5 166,5,133.0,128.8
Aromaticacidsignals 7.48d,(J=7.7)7.65m,7.63m,7.60m,7.52m,7.50m,
7.47m(H-2´,6´)7.61m
128.8,133.2 166.7
Flavonolmoieties,glycosidesof quercetinandkaempferol
8.01(H-2´,6´),6.87(H-3´,5´)(J=7.0)kaempferol 7.05,6.96,6.89(2´,3´and6 ´ofringB)quercetin 6.4-6.7(signalsofH-6,H-8)
5.13d(H-1”)anomericprotonofglucose 1.38(CH3of rhamnose) 108.9,109.4,109.6 96.6-98.7 18.0 140,0163,0
Galloylesterderivatives 7.12brs(galloyl)(H-2´,6´)
6.89,6.94,6.97
6.23d(anomericofsugar)(J=8.2)
5.9m(C3ofglucose)5.6m(C2ofglucose)-deshielded becauseoffurthergalloylsubstitution
4.11sand4.05s(C4andC5ofglucose) 4.74(C6glucose) 108.9 113.9,114.0,114.1 83.2 68.6 77.6and74.5 60.0 134.4,162.3 164,4 165,0 164,4 165,3
Paeoniflorintypecompound 1.39s(CH3,H-10)
1.32(CH2,H-2) 5.43s(H-9) 2.62(H-4) 2.49(CH2,H-5) 7.60t(J=7.6) 17.7 29.0 91.4 43.2 23.2 132.9 86.2(q)C-1 87.5(q)C-6 75.4(q)C-7 106.9,75.4 106.9,75.4 75.4 125.0
Sucrose 5.38d(3.8)anomericproton
3CH2groups3.64,3.73,3.76
91.9 60.6-62.6
13.1,17.3,106.5
Table2
HPLC-DAD-MSqualitativeandquantitativeanalysisofflavonoidsinthemethanolextractsofP.arietinaandP.kesrounansis.
Rt(min) Identification M-H Fragments P.kesrounansis
Aerialparts(mg/g) P.arietina Aerialparts(mg/g) P.kesrounansis Roots(mg/g) P.arietina Roots(mg/g) 12.1 Quercetin-3,7-di-O-glucoside 625 463301 0.39 0.42 0.09 0.06 14.3 Kaemperol-3,7-di-O-glucoside 609 447285 0.40 0.26 0.01 0.04 15.2 Quercetin-hexoside 463 301 1.78 0.70 0.31 0.37 19.7 Quercetin-glucosyl-rhamnoside 609 447463301 3.58 8.50 0.34 0.61 19.1 Quercetin-galloyl-hexoside 615 463301 1.24 0.94 0.05 0.13 18.9 Kaempferol-3-Oglucoside-7-O-ramnoside 593 447463301 3.07 5.57 0.10 0.55 20.0 Rutin 609 301 0.61 0.01 0.02 0.04 Totalamount 11.07 16.4 0.92 1.8
*Dataaremeanofthreedifferentmeasurements.DVSTareintherangeof5%.Rt:Retentiontime.
Fig.6. Generalstructuresofthemainphytoconstituentsidentifiedinthetested methanolextractsofthestudiedPaeoniaspp.extracts.
aerialparts,higherTPCandTFCwereobservedforthemethanol
(172.13mgGAE/gextractand25.84mgRE/gextract,respectively).
Likewise,amongtherootextracts,TPCwashighestinthe
methano-licone(89.06mgGAE/gextract).However,theethylacetateextract
oftherootshowedthehighestTFC(3.33mgRE/gextract)compared
toitscounterpartsolventsextracts.
Apreviousinvestigationby Orhanetal. [16] foundthatthe
ethanolrootextractofthreesubspeciesofP.mascula(western
Ana-tolianP.mascula(L)Mill.,P.mascula(L.)Mill.subsp.arasicola,andP.
mascula(L.)Mill.subsp.bodurii)showedhigherTPC(14.9,14.1,and
14.3mgGAE/100mgextract,respectively)thanP.turcica(7.6mg
GAE/100mgextract)whileP.mascula(easternAnatoliansample)
showedlowerTPC(5.3mgGAE/100mgextract).
3.3. Antioxidantactivity
Severalassaysevaluatingtheantioxidantactivity(DPPH,ABTS,
FRAP,CUPRAC,phosphomolybdenumand metalchelating)were
performedtoobtainacomprehensiveinvitroassessmentofthe
antioxidantpotentialof thetwo testedspecies (see Fig.7).We
usedseveralinvitromethodstostudytheantioxidantproperties
ofextracts.Forexample,DPPHassayisperformedinorganic
sol-vent,whileABTSisperformedinbufferedaqueousphase.FRAPand
CUPRACusetwodifferentmetalionstoassessreducingantioxidant
power.Theothertwo testsinvolved thereduction of
phospho-molybdicacidtophosphomolybdenum,andthemetalchelating
S.Sutetal./JournalofPharmaceuticalandBiomedicalAnalysis165(2019)1–11 7
Table3
HPLC-DAD-MSqualitativeandquantitativeanalysisofgalloylderivativesinthemethanolextractsofP.arietinaandP.kesrounansis.
Rt(min) Compound m/z[M-H]− Fragments Contentofcompoundinmg/g
P.kesrounansis Aerialparts P.arietina Aerialparts P.kesrounansis Roots P.arietina Roots 1.6 Galloylsucrose 493 331,313,179 2.28 3.08 2.59 1.77 3.11 Galloylsucrose 493 331,313,179 3.61 4.02 2.38 1.92 1.5 Glucogalloyl 331 271,221,170 0.55 0.94 0.70 0.52 3.1 Glucogalloyl 331 271,221,170 0.71 0.95 0.70 0.45 10.3 Trigalloylglucose 635 617,465,313,170 0.21 0.86 0.28 0.10 14.0 Trigalloylglucose 635 617,465,313,170 0.10 0.83 0.58 0.29 16.4 Trigalloylglucose 635 617,465,313,170 0.57 0.17 0.15 0.03 15.8 Tetragalloylglucose 787 635,617,465,313 0.64 1.39 0.53 0.38 16.9 Tetragalloylglucose 787 635,617,465,313 0.39 0.64 0.34 0.24 18.9 Tetragalloylglucose 787 635,617,465,313 1.15 3.78 2.09 1.22 19.4 Tetragalloylglucose 787 635617,465,313 2.73 4.86 2.08 1.18 19.9 Galloylpaeoniflorin 631 479,313,169 1.14 2.02 2.07 1.70 21.7 Galloyl-paeoniflorin 631 479,313,169 3.75 0.53 0.73 0.72 22.3 Galloyl-paeoniflorin 631 479,313,169 1.16 0.12 0.15 0.14 22.6 Galloyl-paeoniflorin 631 479,313,169 0.84 0.01 0.03 0.06 23 Galloyl-paeoniflorin 631 479,313,169 2.48 0.11 0.02 0.06 22.7 Pentagalloyl-benzylglucose 891 739,587,569,525,417,170 0.41 0.12 0.03 0.04 23.4 Pentagalloyl-benzylglucose 891 739,587,569,525,417,170 2.23 0.61 0.24 0.25 9 Oxypaeoniflorin 495 465,333,281 0.05 0.10 0.66 0.15 23.6 Trigalloyl-benzylglucose 739 587,569,525,417,170 1.33 0.39 0.20 0.13 18.8 Hexagalloylglucose 1091 939,769,617 24.46 29.96 11.64 13.38 20.3 Paeoniflorin 479 449,327,165,121 3.61 0.18 0.05 0.18 Total 54.43 55.67 28.24 24.9
*Dataaremeanofthreedifferentmeasurements.DVSTareintherangeof5%.Rt:Retentiontime.
Fig.7.Totalphenolic(TPC),totalflavonoid(TFC)andantioxidantpropertiesoftestedPaeoniaextracts(EA:Ethylacetate;MeOH:Methanol;GAE:Gallicacidequivalent;RE: Rutinequivalent:TE:Troloxequivalent;EDTAE:EDTAequivalent).Differentlettersindicateasignificantdifferencebetweentheextracts(p<0.05).
Fig.8. Statisticalevaluations(A&B:DistributionofPaeoniaextractsonthefactorialplanandrepresentationofbiologicalactivitiesonthecorrelationcirclebasedonPCA; C:DendrogramfrombiologicalactivitiesofPaeoniaextracts;D:Correlationcoefficientsbetweentotalbioactivecompoundsandbiologicalactivities(PearsonCorrelation Coefficient(R),p<0.05);EA:Ethylacetate;MeOH:Methanol;AP:Aerialparts;R:Root;TPC:Totalphenoliccontent;TFC:Totalflavonoidcontent).
intheFentonreactiontoproducetoxicfreeradicals.Thepresent
findingsrevealedthatamongtheP.arietinaextracts,the
methano-licaerialpartshowedthehighestDPPH(544.72mgTE/gextract)
andABTS(659.53mgTE/gextract)scavengingactivities.A
simi-larresultwasobservedforP.kesrounansiswherebythemethanol
extractofitsaerialpartsexertedthehighestDPPH(540.23mgTE/g
extract)andABTS(631.83mgTE/gextract)scavengingeffects.
The reducing power, in terms of ferricand cupricreducing
effects,wasdeterminedasshowninFig.7.Amongthethreeextracts
ofP.kesrounansis,themethanolicaerialpartdisplayedthestrongest
reducingeffectinbothassays(CUPRAC:775.09mgTE/gextract;
FRAP:409.12mgTE/gextract).Similarly,themethanolicextract
oftheaerialpartsofP.arietinahadthehighestreducingeffects
(CUPRAC:753.93mgTE/gextract;FRAP:392.96mgTE/gextract)
amongtherespectiveextracts.
Ascanbeobserved,themethanolicextractoftheaerialpartsof
bothplantsshowedthegreatestscavengingandreducingactivities,
whichcouldbecorrelatedtotheamountofbioactivecompoundsin
theextract.Indeed,thegreatestlevelsofphenoliccompoundsand
flavonoidswereobservedinthemethanolicextractoftheaerial
parts,andinfact,anumberofstudiesfoundthatthetotalphenolic
andflavonoidcontentarepositivelycorrelatedwithDPPHandABTS
scavenging,andFRAPandCUPRACreducingactivity[22].Touching
Paeoniaspp.,astudyconductedbyOrhanetal.[16]reportedthat
thecrudeethanolicrootextractsofP.turcica(syn.P.kesrounansis)
anddifferentsubspeciesofP.mascula(syn.P.arietina),includingP.
mascula(westernAnatoliansample),P.mascula(easternAnatolian
sample),andP.masculasubsp.arasicoladisplayedDPPHandnitric
oxidescavengingactivity,whileP.masculasubsp.boduriididnot
showanyDPPHscavengingeffect.
Furthermore,we investigatedthe antioxidantactivity ofthe
extractsbasedonthephosphomolybdenumandmetalchelating
assays.Inthephosphomolybdenum method,Mo(VI)is reduced
toMo(V)bytheantioxidantcompoundsandagreenphosphate
Mo(V)complexisformed.Chelationoftransitionmetalsisalso
importantsincethesemetalscatalyzeFentonreactionwhichplays
amajorroleinoxidativestressinvivo.AmongtheextractsofP.
kesrounansis,themethanolextractoftheaerialpartsshowedthe
greatestactivity(3.46mmolTE/gextractand 33.85mgEDTAE/g
extract in thephosphomolybdenum and metal chelatingassay,
respectively).Thisisalsoinagreementwiththelevelofphenolic
compoundsin theextract. Indeed,a previousstudyby
Sownd-hararajanandKang[23]alsoobservedthatplantextractshowing
highlevelofTPCandTFCdisplayshighactivityinthe
phospho-molybdenumandmetalchelatingassays.ConsideringP.arietina,
thehighestactivityinthephosphomolybdenumassaywasexerted
bytheethyl acetateextract oftheaerialparts (3.78mmolTE/g
extract)whiletheaqueousextractoftheaerialpartsshowed
high-estmetalchelatingeffect(30.57mg EDTAE/gextract).Although
thesetwoextractsweremosteffectiveinthesetwoantioxidant
assays,theydidnotdisplaythehighestTPCandTFC,hence
indicat-ingthepresenceofothercompoundsmodulatingtheirobserved
activities.
3.3.1. Enzymeinhibitoryactivity
Manydrugtherapiesarebasedontheinhibitionoftheactivity
ofoveractiveenzyme(s)toslow-downtheprogressionofdiseases
andtoalleviatetheassociatedsymptoms.Inthepresentstudy,the
enzymeinhibitoryactivityofP.arietinaandP.kesrounansisextracts
againstcholinesterases(AChEand BChE),tyrosinase,␣-amylase,
and␣-glucosidaseweretestedandresultsarepresentedinFig.9.
Cholinesteraseinhibitorsarethemajorclassofdrugswhichare
currentlyutilizedforthesymptomatictreatmentofAlzheimer’s
disease.Cholinesterasesarethemaintargetsofvariousreversible,
irreversibleorpseudo-irreversibleinhibitors,someofwhichmay
cause side effects such as diarrhoea, nausea, vomiting,muscle
cramps,lowbloodpressure,insomnia,fatigue,andlossofappetite
[24].Naturalcompoundsorplantextractsaspossiblesourcesof
therapeuticsforAlzheimer’sdiseasearethereforeintensively
stud-ied.Paeoniaspp.areusedintraditionalmedicineasneuroprotective
[4,6],thereforeweevaluatedPaeoniaextractsaspossibleinhibitors
S.Sutetal./JournalofPharmaceuticalandBiomedicalAnalysis165(2019)1–11 9
Fig.9.EnzymeinhibitoryeffectsoftestedPaeoniaextracts(EA:Ethylacetate;MeOH:Methanol;GALAE:Galatamineequivalent;KAE:Kojicacidequivalent:ACAE:Acarbose equivalent).Differentlettersindicateasignificantdifferencebetweentheextracts(p<0.05).
P.arietina, theethyl acetate extract of theaerial partsshowed
thehighestAChE (4.95mg GALAE/gextract)and BChE(5.73mg
GALAE/gextract)inhibitionfollowedbytheethylacetateextract
oftheroot(4.45and5.05mgGALAE/gextract,respectively).For
P.kesrounansis,themethanolextractoftheaerialpartsandroot
werethemosteffectiveAChE(4.68mgGALAE/gextract)andBChE
(5.98mgGALAE/gextract)inhibitors,respectively.Nosignificant
AChEandBChEinhibitionwasexertedbytheaqueousextractof
therootandaerialpartsofP.kesrounansis,respectively.
Intestinal␣-glucosidaseisakeyenzymeincarbohydrate
diges-tion.It issecreted intheepitheliumof thesmall intestine.The
majorsourceof blood glucose isrepresented bydietary
carbo-hydratesincludingstarch,whichishydrolyzedby␣-glucosidases
andpancreatic␣-amylase,andthenabsorbedbythesmall
intes-tine.Consequently,␣-glucosidaseand␣-amylaseinhibitorshave
beenrecognizedasatherapeutictargetforthecontrolof
postpran-dialhyperglycemia,which istheearliestmetabolicabnormality
thatoccurs intype 2diabetesmellitus[17]. Wefoundthatthe
ethylacetateextractofP.arietinaaerialparts(1.39mmolACAE/g
extract)hadthestrongest␣-amylaseinhibitoryeffectfollowedby
therootone(1.09mmolACAE/gextract).Bothextractsalso
dis-playedthegreatest␣-glucosidaseinhibitioncomparedtotheother
extracts(root ethylacetateextract:10.33mmolACAE/gextract;
aerialpartsethylacetateextract:10.30mmolACAE/gextract).A
similarpatternwasobservedforP.kesrounansis-themost
effec-tive␣-amylaseinhibitorwastheethylacetateextractoftheaerial
parts(1.26mmolACAE/gextract)followedbytherootethylacetate
extract (1.22mmol ACAE/g extract).Likewise, theethyl acetate
extract of the aerial parts displayed the highest ␣-glucosidase
inhibitoryactivity(10.28mmolACAE/gextract).
Itistobenotedthatalthoughtheethylacetateextractsshowed
highenzymeinhibitoryactivitiesagainstAChE,BChE,␣-amylase,
and␣-glucosidase,theycontainedloweramountofphenolicsand
flavonoidcomparedtothemethanolcounterpart.Thenon-direct
correlationbetweenphenolicamountandactivitymightberelated
tospecificactivityofsomecompoundsresponsiblefortheobserved
effectsortosynergisticeffectsofthedifferentcomponentsofthe
wholeextract[25].Itisalsoimportanttonotethatprevious
stud-ies[26]havealsoobservedthehighestAChE,BChE,␣-amylase,and
␣-glucosidaseinhibitoryactivityofethylacetateextractsofplants
comparedtotheirmethanolicandwaterextracts,whichmay
indi-catethatthecompoundsmodulatingtheseeffectmightbemore
solubleinethylacetate.Nonetheless,furtherstudiesareneededto
confirmthishypothesis.
Furthermore,thepresentfindingsrevealedthatbothP.arietina
andP.kesrounansisextractsinhibitedtyrosinase(Fig.9).
Tyrosi-nase, theratelimiting enzymeof the melanogenic pathway,is
a key enzyme in melanin synthesis and it is major
therapeu-tictargettoalleviatecutaneoushyperpigmentation[26].Among
aerialparts (145.43mgKAE/g extract) followed bythat of root
(143.66mgKAE/gextract)displayedthehighesttyrosinase
inhi-bition.Similarly, the most effective tyrosinase inhibitor among
the extracts of P. kesrounansis was the methanolic extract of
theaerialparts(148.34mgKAE/g extract)followed bytheroot
methanolicextract (141.05mg KAE/g extract).The high
tyrosi-naseinhibitory effectof themethanolicextractsof both plants
is likely due to their highest level of phenolic and flavonoid
as found in the present study. Previous investigations [27,28]
showed that plant extracts possessing high level of TPC and
TFCalsodisplayedhighanti-tyrosinaseactivity.Withregardsto
otherPaeoniaspecies,apreviousstudyprovedtheanti-tyrosinase
activity of the methanolic extract of the aerial parts of Greek
P.masculassp.hellenica,displayinganIC50valueof135.2g/ml
[29]. In addition, three isolated compounds from the
flow-ers of P. lactiflora; 1,2,3,6-tetra-O-galloyl-ˇ-D-glucopyranoside,
1,2,3,4,6-penta-O-galloyl-ˇ-D-glucopyranoside and kaempferol
3-O-(6-O-galloyl)-ˇ-D-glucopyranoside, were found to inhibit
tyrosinasewithIC50valuesrangingfrom0.23to0.35g/ml,with
greater effectiveness compared to kojic acid (IC50=6.4g/ml)
[30].
3.3.2. Statisticalevaluation
Principal component (PCA), cluster and correlation analysis
wereperformedtounderstandpossiblerelationsbetweenPaeonia
extracts,componentsandcorrespondingbioactivities.Allresults
aredepictedinFig.8.PCAbuilttwoprincipalcomponents,which
explained82.82% oftotal variability(Fig.8A).ThevariablesTPC,
TFC,DPPH, ABTS, CUPRACand FRAP contribute strongly tothe
formationofaxis1(51.34%),whilethevariablesincluding
tyrosi-nase,amylases,BChEandAChEarestronglycorrelatedtoaxis2
(31.48%).Clearly,astrongcorrelationwasobservedbetweentotal
bioactivecompoundsand antioxidant assays.For example,
cor-relationcoefficientvaluesweremorethan0.9betweenTPCand
DPPH,ABTS,FRAPandCUPRAC.However,anegativecorrelation
wasfoundfor␣-glucosidaseinhibition(Fig.8D).Also,wecould
notethatthemethanolextractsfromtheaerialpartsofthe
Paeo-niaspeciesexhibitedthestrongestantioxidantcapacityamongthe
analyzedextracts(Fig.8B).Likewise,thelowestantioxidantactivity
wasobservedintheaqueousrootextractsofbothspecies.Extracts
fromcorrespondingplantpartsofeachspecieswereclosetoeach
otherandallextractsclusteredasfourgroupsbasedonbiological
activityresults(Fig.8C).
4. Conclusion
Thepresentinvestigationshowedthatthephytochemical
com-position of P. arietina and P. kesrounansis are similar and are
characterizedbygalloylestersandflavonoidglycosides.
Further-more, the extracts showedsignificant antioxidant and enzyme
inhibitoryactivities.Themethanolicextractoftheaerialpartsof
both plantsshowed thehighest antioxidantactivity inmost of
theassays(DPPH,ABTS,CUPRAC,andFRAP)andstrongest
inhi-bitionoftyrosinase.Theethylacetateextractoftheaerialparts
ofbothplantswerethemosteffective␣-amylaseinhibitors.The
rootmethanolicextractofP.kesrounansisshowedthehighestBChE
inhibitionwhiletherootethylacetateextractofP.arietinaexerted
thestrongestinhibitionagainst␣-glucosidase.Thepresent
find-ingsofferpreliminarydataforthevalorizationofPaeoniaspecies
as sources of bioactive constituents with potential use in the
management of severalchronic diseases.Further investigations
shouldbeperformedtoassesstheobservedbioactivitiesbyinvivo
modelsapplyingboththepharmacodynamicandpharmacokinetic
approachandalsotoestablishtheirsafetyprofilethroughtoxicity
studies.
Conflictofinterest
Wewishtoconfirmthattherearenoknownconflictsofinterest
associatedwiththispublicationandtherehasbeennosignificant
financialsupportforthisworkthatcouldhaveinfluencedits
out-come.
Authorcontributions
SS,SD,MG,KS:ChemicalAnalysis;GZ:Biologicalactivity
anal-ysis;GB,AD,MZH:Collectionandidentificationoftheseplantand
GZ,MZA,FM,MFM,SS,SD,KˇS:Dataanalysisandwriting.
Acknowledgement
This workwas supported by the IGA UVPSBrno (grant no.
310/2016/FaF)
References
[1]N.Özhatay,M.Page,M.Sinnott,Plate390.Paeoniaturcica,Curtis’sBot.Mag. 17(2)(2000)92–98.
[2]L.Ji,Q.Wang,J.A.T.daSilva,X.N.Yu,ThegeneticdiversityofPaeoniaL,Sci. Hort.143(2012)62–74.
[3]E.Valiakos,M.Marselos,N.Sakellaridis,T.Constantinidis,H.Skaltsa, Ethnopharmacologicalapproachtotheherbalmedicinesofthe“Antidotes”in NikolaosMyrepsos’Dynameron,J.Ethnopharmacol.163(2015)68–82.
[4]E.Lev,Z.Amar,Ethnopharmacologicalsurveyoftraditionaldrugssoldinthe KingdomofJordan,J.Ethnopharmacol.82(2-3)(2002)131–145.
[5]K.Malik,M.Ahmad,G.Zhang,N.Rashid,M.Zafar,S.Sultana,S.N.Shah, Traditionalplantbasedmedicinesusedtotreatmusculoskeletaldisordersin NorthernPakistan,Eur.J.Integr.Med.19(2018)17–64.
[6]S.Kayani,M.Ahmad,S.Sultana,Z.K.Shinwari,M.Zafar,G.Yaseen,M.Hussain, T.Bibi,EthnobotanyofmedicinalplantsamongthecommunitiesofAlpine andSub-AlpineregionsofPakistan,J.Ethnopharmacol.164(2015)186–202.
[7]H.Sher,R.W.Bussmann,R.Hart,H.J.deBoer,Traditionaluseofmedicinal plantsamongKalasha,IsmaeliandSunnigroupsinChitralDistrict,Khyber Pakhtunkhwaprovince,Pakistan,J.Ethnopharmacol.188(2016)57–69.
[8]Q.Fu,T.Yu,H.-M.Yuan,Y.Song,L.Zou,PaeonidaninsF–H:Threenewdimeric monoterpeneglycosidesfromPaeonialactifloraandtheiranti-inflammatory activity,Phytochem.Lett.13(2015)386–389.
[9]C.Li,K.Yazawa,S.Kondo,Y.Mukudai,D.Sato,Y.Kurihara,T.Kamatani,S. Shintani,TherootbarkofPaeoniamoutanisapotentialanticanceragentin humanoralsquamouscellcarcinomacells,AnticancerRes.32(7)(2012) 2625–2630.
[10]L.Kishore,N.Kaur,R.Singh,NephroprotectiveeffectofPaeoniaemodivia inhibitionofadvancedglycationendproductsandoxidativestressin streptozotocin–nicotinamideinduceddiabeticnephropathy,J.FoodDrug Anal.25(3)(2017)576–588.
[11]E.Tuzlacı,A.Do˘gan,Turkishfolkmedicinalplants,IX:Ovacık(Tunceli), MarmaraPharmaceut.J.14(3)(2010)136–143.
[12]E.Altundag,M.Ozturk,Ethnomedicinalstudiesontheplantresourcesofeast Anatolia,Turkey,ProcediaSoc.Behav.Sci.19(2011)756–777.
[13]S.Akbulut,M.M.Bayramoglu,Thetradeanduseofsomemedicaland aromaticherbsinTurkey,Stud.Ethno-Med.7(2)(2013)67–77.
[14]B.A.Zargar,M.H.Masoodi,B.A.Khan,S.Akbar,PaeoniaemodiRoyle: ethnomedicinaluses,phytochemistryandpharmacology,Phytochem.Lett.6 (2)(2013)261–266.
[15]P.Picerno,T.Mencherini,F.Sansone,P.DelGaudio,I.Granata,A.Porta,R.P. Aquino,ScreeningofapolarextractofPaeoniarockii:compositionand antioxidantandantifungalactivities,J.Ethnopharmacol.138(3)(2011) 705–712.
[16]I.Orhan,B.Demirci,I.Omar,H.Siddiqui,E.Kaya,M.I.Choudhary,G. Ecevit-Genc¸,N.Özhatay,B.S¸ener,K.H.C.Bas¸er,Essentialoilcompositionsand antioxidantpropertiesoftherootsoftwelveAnatolianPaeoniataxawith specialreferencetochromosomecounts,Pharm.Biol.48(1)(2010)10–16.
[17]S.Uysal,G.Zengin,M.Locatelli,M.B.Bahadori,A.Mocan,G.Bellagamba,E.De Luca,A.Mollica,A.Aktumsek,Cytotoxicandenzymeinhibitorypotentialof twoPotentillaspecies(P.speciosaL.andP.reptansWilld.)andtheirchemical composition,Front.Pharmacol.8(2017)290.
[18]R.Li,J.-F.Zhang,Y.-Z.Wu,Y.-C.Li,G.-Y.Xia,L.-Y.Wang,B.-L.Qiu,M.Ma,S.Lin, Structuresandbiologicalevaluationofmonoterpenoidglycosidesfromthe rootsofPaeonialactiflora,J.Nat.Prod.81(2018)1252–1259.
[19]V.U.Ahmad,M.Zubair,M.AtharAbbasi,M.AbidRashid,N.Rasool,S.Nahar Khan,M.IqbalChoudhary,F.Kousar,Structuredeterminationofbioactive galloylderivativesbyNMRspectroscopy,Magn.Reson.Chem.43(6)(2005) 486–488.
[20]M.Blunder,A.Orthaber,R.Bauer,F.Bucar,O.Kunert,Efficientidentificationof flavones,flavanonesandtheirglycosidesinroutineanalysisviaoff-line
S.Sutetal./JournalofPharmaceuticalandBiomedicalAnalysis165(2019)1–11 11
combinationofsensitiveNMRandHPLCexperiments,FoodChem.218(2017) 600–609.
[21]C.He,B.Peng,Y.Dan,Y.Peng,P.Xiao,Chemicaltaxonomyoftreepeony speciesfromChinabasedonrootcortexmetabolicfingerprinting, Phytochemistry107(2014)69–79.
[22]C.A.Can-Cauich,E.Sauri-Duch,D.Betancur-Ancona,L.Chel-Guerrero,G.A. González-Aguilar,L.F.Cuevas-Glory,E.Pérez-Pacheco,V.M.Moo-Huchin, Tropicalfruitpeelpowdersasfunctionalingredients:evaluationoftheir bioactivecompoundsandantioxidantactivity,J.Funct.Food.37(2017) 501–506.
[23]K.Sowndhararajan,S.C.Kang,Freeradicalscavengingactivityfromdifferent extractsofleavesofBauhiniavahliiWight&Arn,Saudi,J.Biol.Sci.20(4) (2013)319–325.
[24]M.Mehta,A.Adem,M.Sabbagh,Newacetylcholinesteraseinhibitorsfor Alzheimer’sdisease,J.AlzheimersDis.(2012)(2012)8.
[25]K.Sonam,S.Guleria,Synergisticantioxidantactivityofnaturalproducts,Ann. Pharmacol.Pharmaceut.2(16)(2017)1086,Article.
[26]G.Zengin,G.Bulut,A.Mollica,M.Z.Haznedaroglu,A.Dogan,A.Aktumsek, BioactivitiesofAchilleaphrygiaandBupleurumcroceumbasedonthe
compositionofphenoliccompounds:invitroandinsilicoapproaches,Food Chem.Toxicol.107(2017)597–608.
[27]N.Wahab,Phenoliccontent,anti-agingandcytotoxicityactivitiesofcocoa beanextractforapotentialuseincosmeceuticals,in:4thWorldCongresson MedicinalPlantsandNaturalProductsResearchAugust08-09,2018Osaka, JapanTheme:NewFrontiersinTransformingFutureofMedicinalPlants,2018.
[28]N.Zamani,M.Gazali,I.Batubara,Thestudyoftyrosinaseandantioxidant activityofXylocarpusgranatumKoenigseedkernelextracttowardevidence basedindigenousknowledgefromTogeanArchipelago,Indonesia,J.Marine Sci.Res.Dev.5(3)(2015)1.
[29]E.Chaita,G.Lambrinidis,C.Cheimonidi,A.Agalou,D.Beis,I.Trougakos,E. Mikros,A.-L.Skaltsounis,N.Aligiannis,Anti-MelanogenicpropertiesofGreek plants.AnoveldepigmentingagentfromMorusalbawood,Molecules22(4) (2017)514.
[30]A.A.Magid,M.Schmitt,P.-C.Prin,L.Pasquier,L.Voutquenne-Nazabadioko,In vitrotyrosinaseinhibitoryandantioxidantactivitiesofextractsand constituentsofPaeonialactifloraPall.flowers,Nat.Prod.J.7(3)(2017) 237–245.